pmc logo image
Logo of gutGutCurrent TOCInstructions to authors

Formats:

Gut. 1995 November; 37(5): 727–730.
PMCID: PMC1382882
Hepatocellular carcinoma and African iron overload.
I T Gangaidzo and V R Gordeuk
Department of Medicine, UZ School of Medicine, University of Zimbabwe, Harare, Zimbabwe.
Abstract
Both hepatocellular carcinoma (HCC) and iron overload are important health problems in Africa. Chronic hepatitis B virus (HBV) infection is recognised as a major risk factor for HCC, but iron overload in Africans has not been considered in pathogenesis. Up to half the patients with HCC in Africa do not have any recognised risk factors such as preceding chronic HBV infection, and other risk factors remain unidentified. HCC is an important complication of HLA-linked haemochromatosis, an iron loading disorder found in Europeans. It is proposed that African iron overload might also be a risk factor for HCC.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (845K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Kew MC, Desmyter J, Bradburne AF, Macnab GM. Hepatitis B virus infection in southern African blacks with hepatocellular cancer. J Natl Cancer Inst. 1979 Mar;62(3):517–520. [PubMed]
  • Peers F, Bosch X, Kaldor J, Linsell A, Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer. 1987 May 15;39(5):545–553. [PubMed]
  • Lutwick LI. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma. Lancet. 1979 Apr 7;1(8119):755–757. [PubMed]
  • Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer. 1992 Jun 19;51(4):537–541. [PubMed]
  • Kew MC. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks. Gastroenterology. 1989 Jul;97(1):136–139. [PubMed]
  • Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. [PubMed]
  • LEEVY CM, GELLENE R, NING M. PRIMARY LIVER CANCER IN CIRRHOSIS OF THE ALCOHOLIC. Ann N Y Acad Sci. 1964 Apr 2;114:1026–1040. [PubMed]
  • BOTHWELL TH, BRADLOW BA. Siderosis in the Bantu. A combined histopathological and chemical study. Arch Pathol. 1960 Sep;70:279–292. [PubMed]
  • Paterson AC, Kew MC, Herman AA, Becker PJ, Hodkinson J, Isaacson C. Liver morphology in southern African blacks with hepatocellular carcinoma: a study within the urban environment. Hepatology. 1985 Jan–Feb;5(1):72–78. [PubMed]
  • Dusheiko G. Hepatocellular carcinoma: molecular biology, etiology and animal models. Gastroenterol Clin North Am. 1987 Dec;16(4):575–590. [PubMed]
  • Barin F, Perrin J, Chotard J, Denis F, N'Doye R, Diop Mar I, Chiron JP, Coursaget P, Goudeau A, Maupas P. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol. 1981;27:148–162. [PubMed]
  • Kew MC, Rossouw E, Hodkinson J, Paterson A, Dusheiko GM, Whitcutt JM. Hepatitis B virus status of southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology. 1983 Jan–Feb;3(1):65–68. [PubMed]
  • Jaskiewicz K, Stepien A, Banach L. Hepatocellular carcinoma in a rural population at risk. Anticancer Res. 1991 Nov–Dec;11(6):2187–2189. [PubMed]
  • Ryder RW, Whittle HC, Sanneh AB, Ajdukiewicz AB, Tulloch S, Yvonnet B. Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts. Am J Epidemiol. 1992 Nov 1;136(9):1122–1131. [PubMed]
  • Larouzé B, Blumberg BS, London WT, Lustbader ED, Sankalé M, Payet M. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa. J Natl Cancer Inst. 1977 Jun;58(6):1557–1561. [PubMed]
  • Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988 May 26;318(21):1355–1362. [PubMed]
  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985 Nov 14;313(20):1256–1262. [PubMed]
  • Loeb LA, James EA, Waltersdorph AM, Klebanoff SJ. Mutagenesis by the autoxidation of iron with isolated DNA. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3918–3922. [PubMed]
  • Hann HW, Stahlhut MW, Hann CL. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology. 1990 Apr;11(4):566–569. [PubMed]
  • Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut. 1988 Nov;29(11):1603–1606. [PubMed]
  • Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, Berman MD. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology. 1988 Nov;95(5):1399–1402. [PubMed]
  • Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet. 1986 Jun 7;1(8493):1310–1313. [PubMed]
  • Gordeuk VR. Hereditary and nutritional iron overload. Baillieres Clin Haematol. 1992 Jan;5(1):169–186. [PubMed]
  • BOTHWELL TH, SEFTEL H, JACOBS P, TORRANCE JD, BAUMSLAG N. IRON OVERLOAD IN BANTU SUBJECTS; STUDIES ON THE AVAILABILITY OF IRON IN BANTU BEER. Am J Clin Nutr. 1964 Jan;14:47–51. [PubMed]
  • HADDOCK DR. BANTU SIDEROSIS IN TANZANIA. East Afr Med J. 1965 Feb;42:67–73. [PubMed]
  • Owor R. Haemosiderosis in Uganda: autopsy study. East Afr Med J. 1974 May;51(5):388–391. [PubMed]
  • DODU SR. Diabetes and haemosiderosis, haemochromatosis, in Ghana. Trans R Soc Trop Med Hyg. 1958 Sep;52(5):425–430. [PubMed]
  • Isah HS, Fleming AF. Anaemia and iron status of symptom-free adult males in northern Nigeria. Ann Trop Med Parasitol. 1985 Oct;79(5):479–484. [PubMed]
  • Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, Ndambire S, Emmanual J, Nkanza N, Chapanduka Z, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 1992 Jan 9;326(2):95–100. [PubMed]
  • HIGGINSON J. THE GEOGRAPHICAL PATHOLOGY OF PRIMARY LIVER CANCER. Cancer Res. 1963 Nov;23:1624–1633. [PubMed]
  • HIGGINSON J. Primary carcinoma of the liver in Africa. Br J Cancer. 1956 Dec;10(4):609–622. [PubMed]
  • HIGGINSON J. Pathogenesis of liver cancer in the Johannesburg area (S. Africa). Acta Unio Int Contra Cancrum. 1957;13(4-5):590–598. [PubMed]
  • HIGGINSON J, GERRITSEN T, WALKER AR. Siderosis in the Bantu of Southern Africa. Am J Pathol. 1953 Jul–Aug;29(4):779–815. [PubMed]
  • HIGGINSON J, DE MEILLON B. Schistosoma haematobium infestation and hepatic disease in man. AMA Arch Pathol. 1955 Sep;60(3):341–346. [PubMed]
  • BUTT EM, HIGGINSON J. Trace element pattern in liver disease and liver carcinoma. Acta Unio Int Contra Cancrum. 1957;13(4-5):599–601. [PubMed]
  • Hershko C. Storage iron regulation. Prog Hematol. 1977;10:105–148. [PubMed]
  • Whittaker P, Skikne BS, Covell AM, Flowers C, Cooke A, Lynch SR, Cook JD. Duodenal iron proteins in idiopathic hemochromatosis. J Clin Invest. 1989 Jan;83(1):261–267. [PubMed]
  • BOTHWELL TH, ABRAHAMS C, BRADLOW BA, CHARLTON RW. IDIOPATHIC AND BANTU HEMOCHROMATOSIS. COMPARATIVE HISTOLOGICAL STUDY. Arch Pathol. 1965 Feb;79:163–168. [PubMed]
  • Brink B, Disler P, Lynch S, Jacobs P, Charlton R, Bothwell T. Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J Lab Clin Med. 1976 Nov;88(5):725–731. [PubMed]
  • Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, Macfarlane BJ, Lamparelli RD, Robinson EJ, Sher R, Hamberg S. Dietary iron overload in southern African rural blacks. S Afr Med J. 1990 Sep 15;78(6):301–305. [PubMed]
  • Gutteridge JM, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond). 1985 Apr;68(4):463–467. [PubMed]
  • Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol. 1978 Oct;40(2):255–263. [PubMed]
  • Gordeuk VR, McLaren GD, Samowitz W. Etiologies, consequences, and treatment of iron overload. Crit Rev Clin Lab Sci. 1994;31(2):89–133. [PubMed]
  • Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992 Jun;119(6):598–620. [PubMed]